Inventiva S.A. - American Depository Shares (IVA) closed at $3.83 on November 2, 2026, up 4.9% from the previous close, on volume of 3,088,741 shares (30-day average 2,855,940).
Data as of November 2, 2026.
Inventiva’s Phase III MASH Catalyst Supports Buy Rating; $12 Price Target Maintained
TipRanks (Mon, 2-Nov 2:45 AM ET)
Inventiva (IVA) Gets a Buy from Leerink Partners
TipRanks (Thu, 29-Oct 8:21 AM ET)
Market Chameleon (Wed, 7-Oct 7:12 AM ET)
Inventiva to Present Scientific Abstracts at AASLD The Liver Meeting 2026
Globe Newswire (Tue, 6-Oct 4:05 PM ET)
Inventiva Reports Unaudited 2026 First-Half Financial Results and Provides Corporate Update
Globe Newswire (Mon, 28-Sep 2:00 AM ET)
Inventiva to Present Multiple Abstracts at Paris MASH 2026
Globe Newswire (Tue, 8-Sep 4:00 PM ET)
Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH
Globe Newswire (Wed, 2-Sep 4:05 PM ET)
Inventiva Appoints Chris Benecchi as Chief Operating Officer
Globe Newswire (Mon, 31-Aug 4:05 PM ET)
Market Chameleon (Tue, 31-Mar 4:37 AM ET)
Inventiva SA is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases with unmet medical needs.
Inventiva S.A. - American Depository Shares trades on the NASDAQ stock market under the symbol IVA.
As of November 3, 2026, IVA stock price climbed to $4.04 with 1,618,722 million shares trading.
IVA has a beta of 0.47, meaning it tends to be less sensitive to market movements. IVA has a correlation of 0.01 to the broad based SPY ETF.
IVA has a market cap of $954.33 million. This is considered a Small Cap stock.
Last quarter Inventiva S.A. - American Depository Shares reported $23,251 in Revenue and -$.29 earnings per share. This fell short of revenue expectation by $-10 million and missed earnings estimates by -$.09.
In the last 3 years, IVA traded as high as $7.98 and as low as $1.53.
The top ETF exchange traded funds that IVA belongs to (by Net Assets): MEDI, APIE.
IVA has underperformed the market in the last year with a return of -6.0%, while the SPY ETF gained +11.8%. In the last 3 month period, IVA fell short of the market, returning -9.8%, while SPY returned +1.3%. However, in the most recent 2 weeks IVA has outperformed the stock market by returning +35.6%, while SPY returned -1.5%.
IVA support price is $3.64 and resistance is $4.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IVA shares will trade within this expected range on the day.
